Q2 2025 Earnings Call February 4, 2025 8:00 AM ETCompany ParticipantsBen Krasinski - Senior Director, IRMichael J.
The healthcare industry is evolving rapidly, and telemedicine has become a cornerstone of modern healthcare delivery. With the global telemedicine market projected to reach 462.19...Read More The post ...
A Wisconsin couple is suing Walgreens and a pharmacy benefits company alleging their son died because he couldn't afford a sudden $500 jump in the cost of his asthma medication.
Walmart’s latest brand and logo update has left some social media ... One poked fun at the new design by posting a screenshot from “The Office” of Jenna Fischer’s character Pam saying ...
University of Calgary's Hotchkiss Brain Institute researchers with the Calgary Stroke Program at Foothills Medical Centre revolutionized treatment for stroke with the ESCAPE Trial, proving that a ...
Ben Krasinski; Director, Investor Relations; Premier Inc. Michael Alkire; President, Chief Executive Officer, Director; Premier Inc. Glenn Coleman; Chief Financial O ...
In a comprehensive Genomic Press Interview, Dr. Kerry Ressler, Chief Scientific Officer at McLean Hospital and Professor of Psychiatry at Harvard Medical School, unveils groundbreaking advances in ...
PhaseV, a pioneer in software and machine learning (ML) for clinical trial optimization, announced today it has entered a strategic partnership with Alimentiv Inc., a global GI (gastrointestinal) ...
Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.
Operator Good day, and welcome to the Centene Corporation fourth quarter and full year 2024 earnings conference call.
Doctors and their patients discuss the range of services that Duke Cancer Institute provides to teens and younger adults with a history of cancer. Beyond Cancer: Mental Health and Therapy Duke ...
Coltrane, a jazz virtuoso who devoted much of her life to a spiritual journey, is a beacon for today’s artists. An exhibition at the Hammer Museum shows why. By Siddhartha Mitter The first ...